Event Schedules

08:00 - 08:30 APSID 2020
08:30 - 09:30 APSID 2020
09:30 - 10:00 APSID 2020
10:00 - 10:30 APSID 2020
10:30 - 11:00 APSID 2020
11:00 - 11:30 APSID 2020
11:30 - 12:00 APSID 2020
12:00 - 12:30 APSID 2020
12:30 - 13:00 APSID 2020
13:00 - 14:00 APSID 2020
14:00 - 14:30 APSID 2020
14:30 - 15:30 APSID 2020
15:30 - 16:00 APSID 2020
16:00 - 16:30 APSID 2020
16:30 - 17:00 APSID 2020
17:00 - 18:30 APSID 2020
17:00 - 18:30 APSID 2020
08:30 - 09:00 APSID 2020
09:30 - 10:30 APSID 2020
10:30 - 11:00 APSID 2020
11:00 - 11:30 APSID 2020
11:30 - 12:30 APSID 2020
12:30 - 13:00 APSID 2020
13:00 - 14:00 APSID 2020
14:00 - 14:30 APSID 2020
14:30 - 15:30 APSID 2020
15:30 - 16:00 APSID 2020
16:00 - 17:00 APSID 2020
08:30 - 09:45
  • 1. Status of PID care in the United States: CIS perspective- Troy R. Torgerson,
  • 2. Status of PID care in Europe: ESID perspective- Isabelle Meyts
  • 3. How has PID care evolved in Latin America?: LASID perspective- Francisco J. Espinosa-Rosales
  • 4. How has PID care evolved in Africa?: ASID perspective- Tandakha Dieye
  • 5. Birth and evolution of PID care in Asia- APSID perspective: Yu Lung Lau
  • 6. PIDs in India: are we different from the rest of the World?: Surjit Singh
09:45 - 10:15
10:15 - 11:50
  • 1. Endemic infections in chronic granulomatous disease - the Asian perspective- Pamela Lee
  • 2. Viral infections in patients with hypogammaglobulinemia: What is our current understanding?: Kohsuke Imai
  • 3. Mycobacterium infections and PIDs: Woei Kang Liew
  • 4. Unusual fungal infections: Almost always PID?- Mukesh Desai
  • 5. Four oral abstracts (To be decided) (5 minutes each)
11:50 - 12:20
  • Panel discussion: Vaccinations in patients with PIDs- Not an easy task for Immunologists?
  • Moderator: Taco Kuijpers
  • Experts Panelists: Godfrey Chi-Fung Chan / Shanmuganathan Chandrakasan /Ankur Jindal / Kohsuke Imai
12:20 - 13:20
12:20 - 14:20
13:20 - 14:35
  • 1. A comprehensive approach to disorders of immune regulation: HirokazuKanegane
  • 2. Auto-inflammatory syndromes: Cross talk between Rheumatology and Immunology: Deepti Suri
  • 3. Atypical and early onset enteropathy: the role of immune and genetic evaluation: ShanmuganathanChandrakasan (Atlanta, USA)
  • 4. Four oral abstracts (To be decided)(5 minutes each)
14:35 - 15:50
  • 1. Hereditary Angioedema: pathogenesis, clinical features and management (45 minutes)- To be decided
  • 2. What’s new under the umbrella of complement deficiency? (20 minutes)- Roshini Abraham
  • 3. Two oral abstracts (To be decided) (5 minutes each)
15:50 - 16:05
16:05 - 17:20
  • 1. Lung involvement in PIDs: An era beyond infections-Francisco J. Espinosa-Rosales
  • 2. Hematological involvement in PIDs: How to manage?: Godfrey Chi-Fung Chan
  • 3. Skin as a window to look into the patient: The hallmark cutaneous manifestations in PIDs: Woei Kang Liew
  • 4. The eye and primary immunodeficiency diseases: an unexpected combination: Martin V Hagen
17:20 - 18:30
  • Presenter: Isabelle Meyts (Clinical) and Dr Kirti Gupta (pathology)
08:30 - 09:55
  • 1. Next generation sequencing in PIDs: Role and disputes- Janet Markle
  • 2. Scope of Next generation sequencing for the diagnosis of PIDs in India: Sheetal Sharda
  • 3. Current status and future prospects of newborn screening for PIDs: Roshini Abraham
  • 4. Flow cytometry: role and limitations in diagnosis of PIDs – Manisha Madkaikar
  • 5. Two oral abstracts (To be decided) (5 minutes each)
09:55 - 10:15
10:15 - 11:55
  • 1. The WAS gene, a single gene defect with multiple clinical phenotypes: Hans Ochs
  • 2. Phenocopies of PID: When to suspect and how to evaluate:Amit Rawat
  • 3. Female carriers of X-linked PIDs: Are they simply carrying the genes?- Taco Kuijpers
  • 4. APDS: Immune abnormalities and metabolism - Xiaodong Zhao
  • 5. STAT3 Hyper-IgE syndrome is much beyond infections- an Indian experience: Biman Saikia
  • 6. Two oral abstracts (To be decided)
11:55 - 12:25
  • How understanding of immune system has improved our management in immunology and rheumatology: Therapeutic implications of immunomodulators and biologics:
  • Moderator: Hirokazu Kanegane
  • Expert Panelists: Troy R. Torgerson/ Isabelle Meyts/ Amita Aggarwal/ Debashish Danda/Martin V Hagen
12:25 - 13:10
  • Topic: “Human Adenosine Deaminase type 2 Deficiency: An Evolving Spectrum”
13:10 - 14:10
13:10 - 14:10
14:10 - 14:57
  • 1. How does one differentiate lymphoproliferation from lymphoma in patients with PIDs- Troy Torgerson
  • 2. EBV associated PIDs and predisposition to malignancy: TandakhaDieye
  • 3. Two oral abstracts (To be decided) (5 minutes each)
14:57 - 15:15
15:15 - 15:45
  • Panel discussion (sponsored session) on intravenous and subcutaneous immunoglobulin replacement therapy
  • Moderator: Hans Ochs
  • Expert Panelists: Nita Radhakrishnan/ Troy R. Torgerson/ Francisco J. Espinosa-Rosales /Nizar Mahlaoui
15:45 - 16:00
16:00 - 17:00
  • 1. HSCT for PID: Patient Care Pathway: Pamela Lee
  • 2. Stem cell transplant in PIDs- Indian Perspective: Revathi Raj
  • 3. Gene therapy- Prospects in Asia: To be decided
  • 4. One oral abstract (to be decided) (5 minutes)
17:00 - 18:00
  • 1. Recent trends in the management of genetic forms of HLH- Shanmuganathan Chandrakasan
  • 2. Recent trends in the management of chronic granulomatous disease: Nizar Mahlaoui
  • 3. Gene variants in PID: New tools in diagnosis and treatment: Martin Van Hagen
  • 4. Oneoral abstract (Te be decided) (5 minutes)
18:00 - 18:10